Unknown

Dataset Information

0

Graphene quantum dots prevent ?-synucleinopathy in Parkinson's disease.

ABSTRACT: Though emerging evidence indicates that the pathogenesis of Parkinson's disease is strongly correlated to the accumulation1,2 and transmission3,4 of ?-synuclein (?-syn) aggregates in the midbrain, no anti-aggregation agents have been successful at treating the disease in the clinic. Here, we show that graphene quantum dots (GQDs) inhibit fibrillization of ?-syn and interact directly with mature fibrils, triggering their disaggregation. Moreover, GQDs can rescue neuronal death and synaptic loss, reduce Lewy body and Lewy neurite formation, ameliorate mitochondrial dysfunctions, and prevent neuron-to-neuron transmission of ?-syn pathology provoked by ?-syn preformed fibrils5,6. We observe, in vivo, that GQDs penetrate the blood-brain barrier and protect against dopamine neuron loss induced by ?-syn preformed fibrils, Lewy body/Lewy neurite pathology and behavioural deficits.

SUBMITTER: Kim D 

PROVIDER: S-EPMC6351226 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Though emerging evidence indicates that the pathogenesis of Parkinson's disease is strongly correlated to the accumulation<sup>1,2</sup> and transmission<sup>3,4</sup> of α-synuclein (α-syn) aggregates in the midbrain, no anti-aggregation agents have been successful at treating the disease in the clinic. Here, we show that graphene quantum dots (GQDs) inhibit fibrillization of α-syn and interact directly with mature fibrils, triggering their disaggregation. Moreover, GQDs can rescue neuronal dea  ...[more]

Similar Datasets

Unknown Electrochemical Method To Prepare Graphene Quantum Dots and Graphene Oxide Quantum Dots.
| S-EPMC6645081 | biostudies-literature
Unknown Graphene quantum dots in photodynamic therapy.
| S-EPMC9419651 | biostudies-literature
Unknown Investigating the Theranostic Potential of Graphene Quantum Dots in Alzheimer's Disease.
| S-EPMC10253610 | biostudies-literature
Unknown Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease.
| S-EPMC4995088 | biostudies-literature
Unknown BPOZ-2 Gene Delivery Ameliorates Alpha-Synucleinopathy in A53T Transgenic Mouse Model of Parkinson's Disease.
| S-EPMC4768134 | biostudies-literature
Unknown Intrastriatal injection of Parkinson's disease intestine and vagus lysates initiates α-synucleinopathy in rat brain.
| S-EPMC9814765 | biostudies-literature
Unknown PPARs and Their Neuroprotective Effects in Parkinson's Disease: A Novel Therapeutic Approach in α-Synucleinopathy?
| S-EPMC9963164 | biostudies-literature
Unknown Applications of Graphene Quantum Dots in Biomedical Sensors.
| S-EPMC7070974 | biostudies-literature
Unknown Size Effect of Graphene Quantum Dots on Photoluminescence.
| S-EPMC8271461 | biostudies-literature
Unknown High-Performance Biomemristor Embedded with Graphene Quantum Dots.
| S-EPMC10708532 | biostudies-literature